These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 20009082

  • 1. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 2. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C, Yan GX, Kocovic D, Kowey PR.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract] [Full Text] [Related]

  • 3. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, Strickberger SA, Sweeney MO, Subcommittee on Electrocardiography and Arrhythmias of the American Heart Association Council on Clinical Cardiology, Heart Rhythm Society.
    Circulation; 2004 Dec 21; 110(25):3866-9. PubMed ID: 15611390
    [Abstract] [Full Text] [Related]

  • 4. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S, Murawski MM.
    J Cardiovasc Pharmacol Ther; 2007 Sep 21; 12(3):175-80. PubMed ID: 17875944
    [Abstract] [Full Text] [Related]

  • 5. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May 21; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 6. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM.
    J Cardiovasc Electrophysiol; 2011 Mar 21; 22(3):280-9. PubMed ID: 20958831
    [Abstract] [Full Text] [Related]

  • 7. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K, Ng DW, Mookadam F.
    Expert Rev Cardiovasc Ther; 2009 Jul 21; 7(7):801-9. PubMed ID: 19589116
    [Abstract] [Full Text] [Related]

  • 8. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J, Abdelhadi R.
    Curr Opin Cardiol; 2013 May 21; 28(3):337-43. PubMed ID: 23549236
    [Abstract] [Full Text] [Related]

  • 9. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb 21; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J, Kerr C, Teo K.
    Can J Cardiol; 2000 Jun 21; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract] [Full Text] [Related]

  • 11. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H, Hindricks G, Kottkamp H.
    Herz; 2005 Nov 21; 30(7):613-8. PubMed ID: 16333587
    [Abstract] [Full Text] [Related]

  • 12. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB, Roy D.
    Can J Cardiol; 2000 Jun 21; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract] [Full Text] [Related]

  • 13. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S, Kasanuki H.
    J Cardiol; 2000 Mar 21; 35 Suppl 1():75-84. PubMed ID: 10834174
    [Abstract] [Full Text] [Related]

  • 14. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME.
    Nat Clin Pract Cardiovasc Med; 2006 Mar 21; 3(3):115. PubMed ID: 16505838
    [No Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R, Shah AJ, Keebler M, Thakur RK.
    Cardiol Clin; 2009 Feb 21; 27(1):151-61, ix-x. PubMed ID: 19111771
    [Abstract] [Full Text] [Related]

  • 16. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT, Varosy PD, Masoudi FA.
    JAMA Intern Med; 2013 May 27; 173(10):859-65. PubMed ID: 23546173
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J, Cabrera JA, Romero J, Rubio JM.
    Am J Cardiol; 2000 Nov 02; 86(9A):44K-51K. PubMed ID: 11084100
    [Abstract] [Full Text] [Related]

  • 18. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.
    Herz; 2005 Mar 02; 30(2):91-101. PubMed ID: 15875097
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M.
    Europace; 2014 Feb 02; 16(2):227-34. PubMed ID: 24108231
    [Abstract] [Full Text] [Related]

  • 20. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ, Krahn A, Klein G.
    Can J Cardiol; 2000 Jun 02; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.